1.50INR
37.71 MINR
4.18 BINR
About AAREY DRUGS & PHARM LTD
Sector
CEO
Mihir Rajesh Ghatalia
Headquarters
Mumbai
Website
Founded
1990
ISIN
INE198H01019
FIGI
BBG000D2FKB7
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.
Buy in dips Stock 3 - Aarey DrugsBuy above 30 with the stop loss of 24. Targets are 42, 54 and 66.
Duration : One year. Note : Consult your financial advisor before investing.
Aarey Drugs- Sign of Trend Reversal..?Accumulate
59-61
Target
65
70
75
SL below 56 CBSL
For educational purpose only, Not responsible for any financial Loss
Not SEBI registered
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AAREYDRUGS is 46.60 INR — it has decreased by 1.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AAREY DRUGS & PHARM LTD stocks are traded under the ticker AAREYDRUGS.
AAREY DRUGS & PHARM LTD is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
AAREYDRUGS stock is 4.02% volatile and has beta coefficient of 0.22. Check out the list of the most volatile stocks — is AAREY DRUGS & PHARM LTD there?
Yes, you can track AAREY DRUGS & PHARM LTD financials in yearly and quarterly reports right on TradingView.
AAREYDRUGS stock has fallen by 1.89% compared to the previous week, the month change is a 16.50% rise, over the last year AAREY DRUGS & PHARM LTD has showed a 76.18% increase.
AAREYDRUGS net income for the last quarter is 19.08 M INR, while the quarter before that showed 7.85 M INR of net income which accounts for 143.14% change. Track more AAREY DRUGS & PHARM LTD financial stats to get the full picture.
Today AAREY DRUGS & PHARM LTD has the market capitalization of 1.22 B, it has increased by 2.32% over the last week.
AAREY DRUGS & PHARM LTD dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AAREYDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AAREY DRUGS & PHARM LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AAREY DRUGS & PHARM LTD technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AAREY DRUGS & PHARM LTD stock shows the buy signal. See more of AAREY DRUGS & PHARM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AAREY DRUGS & PHARM LTD EBITDA is 37.12 M INR, and current EBITDA margin is 2.64%. See more stats in AAREY DRUGS & PHARM LTD financial statements.